EU Joint Programme – Neurodegenerative Disease Research (JPND): Understanding the Mechanisms of non-Pharmacological Interventions


The European Union Joint Programme on Neurodegenerative Disease Research (JPND), a global research initiative with 30 member countries, has launched a transnational call for research projects on understanding the mechanisms of non-pharmacological interventions for Alzheimer’s disease, Parkinson’s disease, motor neuron disease and other neurodegenerative diseases.

Together, Brain Canada and Canadian Institutes of Health Research (CIHR) will support up to 3 projects (max. amount $333,000 per grant over 3 years). Brain Canada funds will go toward one project with a focus on Parkinson’s disease, and CIHR funds are available to support research relevant to any area of the JPDN call.

Evidence clearly shows that increasing equity, diversity, and inclusion (EDI) in research environments enhances excellence, innovation and creativity. Brain Canada and CIHR are committed to excellence through equity, and we encourage applicants of diverse backgrounds to apply to our funding opportunities.

Click here for more information.  

Deadline for receipt of pre-proposals: March 1, 2022, at 6:00 a.m. ET

Deadline for full proposals: June 28, 2022, at 6:00 a.m. ET

Agency Name: 
European Union Joint Programme on Neurodegenerative Disease Research (JPND)
Contact Name:
Grant Amount: 
$333,000 per grant over 3 years
Grant Location: 
External Deadline: 
Tuesday, March 1, 2022
Internal Deadline: 
Tuesday, February 22, 2022
Grant Type: 
Grant Area: 
Grant Eligibility: